Cite

    Slevin, F. et al. (2020). Response to 'Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer'. Clinical and translational radiation oncology. pp. 52-. [Online].